全文获取类型
收费全文 | 209篇 |
免费 | 3篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 1篇 |
妇产科学 | 19篇 |
基础医学 | 11篇 |
临床医学 | 16篇 |
内科学 | 57篇 |
神经病学 | 25篇 |
特种医学 | 17篇 |
外科学 | 22篇 |
预防医学 | 5篇 |
药学 | 7篇 |
中国医学 | 1篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 3篇 |
2019年 | 4篇 |
2018年 | 2篇 |
2017年 | 4篇 |
2016年 | 5篇 |
2015年 | 4篇 |
2014年 | 5篇 |
2013年 | 7篇 |
2012年 | 13篇 |
2011年 | 13篇 |
2010年 | 6篇 |
2009年 | 5篇 |
2008年 | 8篇 |
2007年 | 5篇 |
2006年 | 13篇 |
2005年 | 8篇 |
2004年 | 7篇 |
2003年 | 6篇 |
2002年 | 9篇 |
2001年 | 11篇 |
2000年 | 9篇 |
1999年 | 11篇 |
1998年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1993年 | 2篇 |
1992年 | 7篇 |
1991年 | 7篇 |
1990年 | 4篇 |
1989年 | 5篇 |
1988年 | 4篇 |
1987年 | 2篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1978年 | 1篇 |
1976年 | 1篇 |
1973年 | 3篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有213条查询结果,搜索用时 31 毫秒
1.
J. M. García Santos J. Martínez-Lage A. Gilabert Ubeda A. Capel Alemán V. Climent Oltrá 《Neuroradiology》1993,35(5):355-358
Arachnoid cysts situated in the middle cranial fossa constitute the largest group of this type of lesion. Their origin has been the subject of debate since they were first described. There is still controversy as to whether they originate directly from the meninges adjacent to the temporal pole or whether partial agenesis of the temporal lobe favours secondary formation of the cyst. We assessed the morphology of the temporal lobe and the bulging of the squamous temporal bone. Paradoxical changes in adjacent-bone, described as very rare findings in arachnoid cysts of the middle cranial fossa, were common in our study and suggest, in association with direct signs of temporal atrophy, that this atrophy precedes, or is at least coexistent with, the formation of the cyst. The importance of being able to determine the origin of the cyst lies in its being a factor to assess as regards treatment. 相似文献
2.
3.
Mestron A Webb SM Astorga R Benito P Catala M Gaztambide S Gomez JM Halperin I Lucas-Morante T Moreno B Obiols G de Pablos P Paramo C Pico A Torres E Varela C Vazquez JA Zamora J Albareda M Gilabert M 《European journal of endocrinology / European Federation of Endocrine Societies》2004,151(4):439-446
OBJECTIVE: To undertake a multicentre epidemiological study reflecting acromegaly in Spain. DESIGN: Voluntary reporting of data on patients with acromegaly to an online database, by the managing physician. METHODS: Data on demographics, diagnosis, estimated date of initial symptoms and diagnosis, pituitary imaging, visual fields, GH and IGF-I concentrations (requested locally), medical, radiotherapy and neurosurgical treatments, morbidity and mortality were collected. RESULTS: Data were included for 1219 patients (60.8% women) with a mean age at diagnosis of 45 years (s.d. 14 years). Reporting was maximal in 1997 (2.1 cases per million inhabitants (c.p.m.) per year); prevalence was globally 36 c.p.m., but varied between 15.7 and 75.8 c.p.m. in different regions. Of 1196 pituitary tumours, most were macroadenomas (73%); 81% of these patients underwent surgery, 45% received radiotherapy and 65% were given medical treatment (somatostatin analogues in 68.3% and dopamine agonists in 31.4%). Cures (GH values (basal or after an oral glucose tolerance test) <2 ng/ml, normal IGF-I, or both) were observed in 40.3% after surgery and 28.2% after radiotherapy. Hypertension (39.1%), diabetes mellitus (37.6%), hypopituitarism (25.7%), goitre (22.4%), carpal tunnel syndrome (18.7%) and sleep apnoea (13.2%) were reported as most frequent morbidities; 6.8% of the patients had cancer (breast in 3.1% of the women and colon in 1.2% of the cohort). Fifty-six patients died at a mean age of 60 years (s.d. 14 years), most commonly of a cardiovascular cause (39.4%); mortality was greater in patients given radiotherapy (hazard ratio 2.29; 95% confidence interval 1.03 to 5.08; P=0.026), and in those in whom GH and IGF-I concentrations were never normal (P<0.001). CONCLUSIONS: This acromegaly registry offers a realistic overview of the epidemiological characteristics, treatment outcome and morbidity of acromegaly in Spain. As active disease and treatment with radiotherapy are associated with an increase in mortality, efforts to control the disease early are desirable. 相似文献
4.
Bile-Duct Hamartomas Presenting as Multiple Focal Lesions on Hepatic Ultrasonography 总被引:1,自引:0,他引:1
Joan Saló M.D. Concepció Bru M.D. Angels Vilella M.D. Pere Ginés M.D. Rosa Gilabert M.D. Antoni Castells M.D. Miquel Bruguera M.D. Joan Rodés M.D. 《The American journal of gastroenterology》1992,87(2):221-223
Multiple bile-duct hamartomas are usually diagnosed at autopsy as an incidental finding. We report a case of a 50-yr-old male in whom multiple bile-duct hamartomas were suspected in an abdominal ultrasonography and confirmed by an echo-guided needle liver biopsy. The ultrasonography disclosed multiple scattered hyperechoic lesions with a diameter of up to 1 cm, associated with some anechoic lesions of a larger size and a cystic appearance. Computed tomography demonstrated multiple hypodense lesions that were not modified by the administration of contrast. Bile-duct hamartomas should be included in the differential diagnosis of multiple focal hepatic lesions at ultrasonography or computed tomography. 相似文献
5.
Ortega E Gilabert R Nuñez I Cofán M Sala-Vila A de Groot E Ros E 《Atherosclerosis》2012,220(1):275-281
ObjectiveRelationship of high sensitivity C-reactive protein (hsCRP) with Metabolic Syndrome (MetS) is well documented in many populations, but comprehensive data is lacking in Indian population. Thus, we set out to investigate the association of hsCRP levels with MetS and its features and the effect of obesity and insulin resistance on this association in urban Indians.MethodsThis is a cross-sectional study that included 9517 subjects comprising 4066 subjects with MetS. MetS was defined according to the modified National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III) criteria for Asians.ResultsMedian levels of hsCRP were considerably higher in individuals with MetS with higher levels in women compared to men. Among the features of MetS, waist circumference was most strongly correlated with hsCRP levels (r = 0.28) and contributed maximally (β = 0.025 mg/l ln hsCRP, P = 7.4 × 10?147). Subjects with high risk hsCRP levels (>3 mg/l) were at high risk of MetS (OR (95% CI) = 1.65(1.41–1.92), P = 1.7 × 10?10). Risk of MetS increased in a dose dependent manner from low risk to high risk hsCRP category with increase in BMI and HOMA-IR.ConclusionsOur findings suggest that hsCRP predicts the risk of MetS, independent of obesity and insulin resistance, and therefore, can be a valuable tool to aid the identification of individuals at risk of MetS. The study provides a lead for future investigation for effects of hsCRP, obesity, and insulin resistance on MetS in this population. 相似文献
6.
Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis 总被引:7,自引:0,他引:7
Perelló A Escorsell A Bru C Gilabert R Moitinho E García-Pagán JC Bosch J 《Hepatology (Baltimore, Md.)》1999,30(6):1393-1397
Wedged hepatic venous pressure (WHVP) is equivalent to portal venous pressure in patients with alcoholic liver diseases. However, it may underestimate portal pressure in nonalcoholics, which is important because hepatitis C virus (HCV) infection is a frequent cause of chronic liver disease. We investigated the agreement between directly measured portal pressure and WHVP in alcoholic and HCV-related liver diseases. Seventy-one patients with liver disease resulting from HCV infection (n = 32), alcohol (n = 25), or both (n = 14) underwent simultaneous measurements of WHVP (by hepatic vein catheterization) and portal pressure (by direct puncture). In 9 patients, measurements were repeated 20 minutes after acute iv propranolol administration. WHVP showed an excellent agreement with portal pressure in patients with cirrhosis resulting from either HCV, alcohol or both (intraclass correlation coefficient: 0.94, 0.93, and 0.97, respectively; P <.001). A discrepancy of >/=5 mm Hg was observed in 7 cases. WHVP underestimated portal pressure in only 1 case and exceeded portal pressure by >/=5 mm Hg in 6 patients. The WHVP response to propranolol closely and significantly correlated with changes in portal pressure (intraclass correlation coefficient: 0.87; P <.004). The simple and safe measurement of WHVP accurately reflects portal pressure in alcoholic and HCV-related liver disease. This technique also allows us to accurately assess the portal pressure response to propranolol in both alcoholic and HCV-related cirrhosis. 相似文献
7.
Marta Malagn Sara Rami‐Pujol Marta Serrano Mariona Serra‐Pags Joan Amoedo Lia Oliver Anna Bahí Teresa MasdeXaxars Leyanira Torrealba Pau Gilabert Josep Oriol Miquel‐Cusachs Laura García‐Nimo Joan Sal Jordi Guardiola Virginia Piol Joaquin Cubiella Antoni Castells Xavier Aldeguer Jesús Garcia‐Gil 《Alimentary pharmacology & therapeutics》2019,49(11):1410-1420
8.
9.
This paper presents the experience in the use of a validation protocol for the125I seeds reference air Kerma rate used in prostate treatments before being implanted. The method used employs a well-type ionization chamber that has been calibrated against an international standard at an accredited dosimetry calibration laboratory (ADCL), this is a direct traceability system. Then, as a quality control check on the well-chamber’s response, the calibration factors are assayed on an ADCL calibrated125I seed, secondary traceability system. Before each assay procedure a long-lived source, which dosimetric characteristics are well known, is placed in the well-chamber as a redundancy program to verify that our dosimetry system has not changed with time. Finally the results of verifications over a 2-year period are discussed. 相似文献
10.